The rupee devaluation has had a negative impact on the competitiveness of Pakistan’s pharmaceutical industry. The industry in Pakistan is local-market oriented due to significant barriers of entry to the export market. The devaluation makes pharma products less attractive to foreign purchasers. There are stringent regulations being placed by DRAP in terms of pricing which are somewhat affecting the industry adversely.
Pharmaceutical companies cannot meet their expenses from the current pricing structure because of which they are bound to demand an increase in price. These companies also have to import specific active pharma ingredients in order to manufacture medicine. This means it costs more to produce a pill in rupees which leads to lower margins and competitiveness in the market due to devaluation. The decrease and slowing down on the competition, however, is beneficial to the public, and to an extent, to the pharma industry. Therefore, having a rate which is feasible for both the industry and public is a better option.
Mehr Aftab
Toronto, Canada
The ongoing political upheaval and conflicts among leaders aren’t just theoretical issues; they have tangible, daily...
The International Cricket Council has recently faced criticism for seemingly excluding certain cities from the ICC...
The country is facing an increasingly dire water shortage due to a combination of internal and external factors....
Islamabad’s roads are under stress due to heavy traffic. As a result, traffic deaths are rising in the capital...
The pervasive influence of social media has transformed the way we interact, consume information, and perceive the...
Karachi’s real estate market may be booming, but this growth has come at the expense of millions of middle and...
